Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy
Hannah Hussey, Mary-Ann Davies, Alexa Heekes, Carolyn Williamson, Ziyaad Valley-Omar, Diana Hardie, Stephen Korsman, Deelan Doolabh, Wolfgang Preiser, Tongai Maponga, Arash Iranzadeh, Susan Engelbrecht, Sean Wasserman, Neshaad Schrueder, Linda Boloko, Greg Symons, Peter Raubenheimer, Abraham Viljoen, Arifa Parker, View ORCID ProfileCheryl Cohen, Waasila Jassat, Richard Lessells, Robert J Wilkinson, Andrew Boulle, Nei-yuan Hsiao
doi: https://doi.org/10.1101/2021.10.23.21265412
Hannah Hussey
1Health Intelligence, Western Cape Government: Health, South Africa
2Division of Public Health Medicine, School of Public Health and Family Medicine, University of Cape Town, South Africa
Mary-Ann Davies
1Health Intelligence, Western Cape Government: Health, South Africa
3Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, South Africa
Alexa Heekes
1Health Intelligence, Western Cape Government: Health, South Africa
2Division of Public Health Medicine, School of Public Health and Family Medicine, University of Cape Town, South Africa
Carolyn Williamson
4Division of Medical Virology, University of Cape Town, Cape Town, Western Cape, South Africa
5National Health Laboratory Service, South Africa
6Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
Ziyaad Valley-Omar
4Division of Medical Virology, University of Cape Town, Cape Town, Western Cape, South Africa
5National Health Laboratory Service, South Africa
Diana Hardie
4Division of Medical Virology, University of Cape Town, Cape Town, Western Cape, South Africa
5National Health Laboratory Service, South Africa
Stephen Korsman
4Division of Medical Virology, University of Cape Town, Cape Town, Western Cape, South Africa
5National Health Laboratory Service, South Africa
Deelan Doolabh
4Division of Medical Virology, University of Cape Town, Cape Town, Western Cape, South Africa
5National Health Laboratory Service, South Africa
Wolfgang Preiser
5National Health Laboratory Service, South Africa
7Division of Medical Virology, University of Stellenbosch, South Africa
Tongai Maponga
5National Health Laboratory Service, South Africa
7Division of Medical Virology, University of Stellenbosch, South Africa
Arash Iranzadeh
4Division of Medical Virology, University of Cape Town, Cape Town, Western Cape, South Africa
5National Health Laboratory Service, South Africa
Susan Engelbrecht
5National Health Laboratory Service, South Africa
7Division of Medical Virology, University of Stellenbosch, South Africa
Sean Wasserman
6Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
8Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, South Africa
Neshaad Schrueder
10Department of Medicine, Tygerberg Hospital, Stellenbosch University, South Africa
Linda Boloko
6Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
9Department of Medicine, Groote Schuur Hospital, University of Cape Town, South Africa
Greg Symons
9Department of Medicine, Groote Schuur Hospital, University of Cape Town, South Africa
Peter Raubenheimer
9Department of Medicine, Groote Schuur Hospital, University of Cape Town, South Africa
Abraham Viljoen
10Department of Medicine, Tygerberg Hospital, Stellenbosch University, South Africa
Arifa Parker
10Department of Medicine, Tygerberg Hospital, Stellenbosch University, South Africa
Cheryl Cohen
11National Institute for Communicable Diseases, Johannesburg, South Africa
12School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Waasila Jassat
11National Institute for Communicable Diseases, Johannesburg, South Africa
Richard Lessells
13KwaZulu-Natal Research, Innovation & Sequencing Platform, University of KwaZulu-Natal, Durban, South Africa
Robert J Wilkinson
6Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
14The Francis Crick Institute, Midland Road, London, NW1 1AT, UK
15Department of Infectious Diseases, Imperial College London, W12 0NN, UK
Andrew Boulle
1Health Intelligence, Western Cape Government: Health, South Africa
3Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, South Africa
Nei-yuan Hsiao
4Division of Medical Virology, University of Cape Town, Cape Town, Western Cape, South Africa
5National Health Laboratory Service, South Africa
6Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted October 26, 2021.
Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy
Hannah Hussey, Mary-Ann Davies, Alexa Heekes, Carolyn Williamson, Ziyaad Valley-Omar, Diana Hardie, Stephen Korsman, Deelan Doolabh, Wolfgang Preiser, Tongai Maponga, Arash Iranzadeh, Susan Engelbrecht, Sean Wasserman, Neshaad Schrueder, Linda Boloko, Greg Symons, Peter Raubenheimer, Abraham Viljoen, Arifa Parker, Cheryl Cohen, Waasila Jassat, Richard Lessells, Robert J Wilkinson, Andrew Boulle, Nei-yuan Hsiao
medRxiv 2021.10.23.21265412; doi: https://doi.org/10.1101/2021.10.23.21265412
Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy
Hannah Hussey, Mary-Ann Davies, Alexa Heekes, Carolyn Williamson, Ziyaad Valley-Omar, Diana Hardie, Stephen Korsman, Deelan Doolabh, Wolfgang Preiser, Tongai Maponga, Arash Iranzadeh, Susan Engelbrecht, Sean Wasserman, Neshaad Schrueder, Linda Boloko, Greg Symons, Peter Raubenheimer, Abraham Viljoen, Arifa Parker, Cheryl Cohen, Waasila Jassat, Richard Lessells, Robert J Wilkinson, Andrew Boulle, Nei-yuan Hsiao
medRxiv 2021.10.23.21265412; doi: https://doi.org/10.1101/2021.10.23.21265412
Subject Area
Subject Areas
- Addiction Medicine (403)
- Allergy and Immunology (712)
- Anesthesia (207)
- Cardiovascular Medicine (2969)
- Dermatology (253)
- Emergency Medicine (445)
- Epidemiology (12806)
- Forensic Medicine (12)
- Gastroenterology (830)
- Genetic and Genomic Medicine (4621)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2941)
- Health Policy (1073)
- Hematology (393)
- HIV/AIDS (932)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (475)
- Neurology (4408)
- Nursing (238)
- Nutrition (649)
- Oncology (2295)
- Ophthalmology (652)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (281)
- Palliative Medicine (84)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (502)
- Public and Global Health (7004)
- Radiology and Imaging (1544)
- Respiratory Medicine (921)
- Rheumatology (444)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)